SCHEMBL24841630

SCHEMBL24841630

c1ccc(-c2ccc(N(c3ccc(-c4ccccc4)cc3)c3ccc4c(c3)C(c3ccccc3)(c3ccccc3)c3cc(-c5cccc(-c6ccc7ccccc7c6)c5)ccc3-4)cc2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSD17B1 P14061 1/20 0.37
▸ HSD17B2 P37059 1/20 0.37
▸ ESR1 P03372 3/20 0.36
▸ ESR2 Q92731 3/20 0.36
▸ PDK2 Q15119 1/20 0.35
▸ CHRNB2 P17787 2/20 0.34
▸ CHRNB4 P30926 2/20 0.34
▸ CHRNA3 P32297 2/20 0.34
▸ CHRNA4 P43681 2/20 0.34
▸ SLC6A2 P23975 2/20 0.34
▸ SLC6A4 P31645 2/20 0.34
▸ SLC6A3 Q01959 2/20 0.34
▸ CHRNA1 P02708 1/20 0.34
▸ CHRNG P07510 1/20 0.34
▸ CHRNB1 P11230 1/20 0.34
▸ CHRND Q07001 1/20 0.34
▸ CYP1A1 P04798 1/20 0.34
▸ CYP1B1 Q16678 1/20 0.34
▸ ACMSD Q8TDX5 1/20 0.33
▸ CYP11B1 P15538 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10034357 0.97 ESR1 (0.37) HSD17B1HSD17B2ESR1ESR2PDK2
SCHEMBL20466619 0.97 ESR1 (0.37) HSD17B1HSD17B2ESR1ESR2PDK2
SCHEMBL17243470 0.96 ESR1 (0.36) HSD17B1HSD17B2ESR1ESR2PDK2
SCHEMBL17243473 0.96 ESR1 (0.36) HSD17B1HSD17B2ESR1ESR2PDK2
SCHEMBL24255717 0.95 PDK2 (0.36) HSD17B1HSD17B2ESR1ESR2PDK2
SCHEMBL24842281 0.95 PDK2 (0.36) HSD17B1HSD17B2ESR1ESR2PDK2
SCHEMBL23180038 0.95 PDK2 (0.36) HSD17B1HSD17B2ESR1ESR2PDK2
SCHEMBL23180013 0.95 PDK2 (0.36) HSD17B1HSD17B2ESR1ESR2PDK2
SCHEMBL23179402 0.95 PDK2 (0.36) HSD17B1HSD17B2ESR1ESR2PDK2
SCHEMBL24841513 0.95 PDK2 (0.36) HSD17B1HSD17B2ESR1ESR2PDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230006136-A1 COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT MATERIAL, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-01-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230006136-A1 COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT MATERIAL, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE PIEZO1, LEF1, POU2F1 HSD17B1 2198/4885HSD17B2 2307/4885ESR1 30/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback